Back to results
RecruitingN/A

HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

NCT04472845

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Budhi Singh Yadav

Chandigarh, India

Contact

BUDHI S YADAV, MD

9815981176drbudhi@gmail.com
View on ClinicalTrials.gov
HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART). — TrialFind